CRUN
CRUN
CRUN
| STUDY TITLE | TYPE OF STUDY | FINANCIAL SUPPORT |
| Mal076: Extension to study Malaria-055 PRI (110021) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’candidate malaria vaccine (SB257049) in infants and children in Africa | Phase III | GlaxoSmithKline (GSK) Biologicals
|
Input your search keywords and press Enter.
